269 filings
Page 3 of 14
8-K
id3 9akig1
15 Aug 22
Sonnet BioTherapeutics Provides Fiscal Year 2022 Third Quarter Business and Earnings Update
4:32pm
8-K
0mrk4
23 Jun 22
Submission of Matters to a Vote of Security Holders
4:56pm
8-K
6v59gn40
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
xpljid
10 May 22
Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update
7:05am
8-K
pgjz6 jfocbzhi
11 Apr 22
Amendments to Articles of Incorporation or Bylaws
5:03pm
8-K
cuug b9x26
8 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:10pm
8-K
03fbu7fa1z7y7
16 Mar 22
Other Events
7:05am
8-K
e9esu i9rm5e
8 Feb 22
Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
7:13am
8-K
yfbsq5hhn
17 Dec 21
Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update
7:39am
8-K
gbrwq5 8q
7 Oct 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:51pm
8-K
t4fkc vs03c
31 Aug 21
Other Events
7:55am
8-K
iiunm0 r0ymyxm8
25 Aug 21
Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public
12:00am
8-K
3jt 49724m
19 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2:10pm
8-K
75t8y
16 Aug 21
Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update
7:50am
8-K
4reisciv0
15 Jul 21
Submission of Matters to a Vote of Security Holders
4:53pm
8-K
3p9b9pxr3iz
14 Jun 21
Other Events
9:05am
8-K
9fgmxy
8 Jun 21
Other Events
5:17pm
8-K
ibjt2j7
21 May 21
Departure of Directors or Certain Officers
5:04pm
8-K
hmo0t3vo
17 May 21
Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update
8:37am
8-K
ve22k
14 May 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:24pm